The cost-effectiveness of treatments for male infertility

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 8, Issue 2, 2008, Pages 197-206

  Movassaghi, Mehran ^a   Turek, Paul J ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cost benefit; Decision analysis; Male infertility; Markov model; Varicocele; Vasectomy

Indexed keywords

ACETYLCYSTEINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA SYMPATHOMIMETIC AGENT; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTIESTROGEN; ANTIOXIDANT; ASCORBIC ACID; CARNITINE; CLOMIFENE CITRATE; CORTICOSTEROID; ESSENTIAL FATTY ACID; FOLIC ACID; FOLLITROPIN; GLUTATHIONE; GONADOTROPIN; LEVACECARNINE; LUTEINIZING HORMONE; TESTOSTERONE; ZINC;

CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE ASSOCIATION; DOSE RESPONSE; EJACULATION DISORDER; EJACULATORY DUCT OBSTRUCTION; FERTILIZATION IN VITRO; HEALTH CARE COST; HORMONAL THERAPY; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INTRACYTOPLASMIC SPERM INJECTION; MALE; MALE GENITAL SYSTEM SURGERY; MALE INFERTILITY; NONHUMAN; PREGNANCY RATE; REVIEW; SPERM RETRIEVAL; SPERMATOZOON CAPACITATION; SPERMATOZOON COUNT; UNSPECIFIED SIDE EFFECT; VARICOCELE; VASECTOMY; VASOEPIDIDYMOSTOMY; VASOVASOSTOMY; ZINC DEFICIENCY;

EID: 46949101162     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.8.2.197     Document Type: Review

References (57)

1. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 340(8810), 17-18 (1992).
2. Clermont Y, Heller C. Spermatogenesis in man: an estimate of its duration. Science (140), 184-185 (1963).
3. Franca LR, Avelar GF, Almeida FFL. Spermatogenesis and sperm transit through the epididymis with emphasis on pigs. Theriogenology (63), 300-318 (2005).
4. Misell LM, Holochwost D, Boban D et al. A stable isotope/mass spectrometric method for measuring the kinetics of human spermatogenesis in vivo. J. Urol. (175), 242-246 (2006).
5. Turek P. Practical approaches to the diagnosis and management of male infertility. Nat. Clin. Pract. Urol. 2(5), 226-238 (2005).
6. Schiff J, Ramirez M, Bar-Chama N. Medical and surgical management male infertility. Endocrinol. Metab. Clin. N. Am. 36(2), 313-331 (2007).
7. Lui P, Handelsman D. The present and future state of hormonal treatment for male infertility. Hum. Reprod. Update 9(1), 9-23 (2003).
8. Haidl G. Management strategies for male factor infertility. Drugs 62(12), 1741-1753 (2002).
9. Haidl G, Schill WB. Guidelines for drug treatment of male infertility. Drugs 41(1), 60-68 (1991).
10. Sigman M, Jarow JP. Endocrine evaluation of infertile men. Urology 50(5), 659-664 (1997).
11. Burris AS, Clark RV, Vantman DJ, Sherins RJ. A low sperm concentration does not preclude fertility in men with isolated hypogondatropic hypogonadism after gonadotropin therapy. Fertil Steril. 50(2), 343-347 (1988).
12. Caroppo E, Niederberger C, Vizziello GM, D'Amato G. Use of recombinant follicle stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoosperic patients undergoing intracytoplasmic sperm injection. Fertil. Steril. 80(6), 1398-1406 (2003).
13. Ashkenazi J, Bar-Hava I, Farhi J et al. The role of purified follicle stimulating hormone therapy in the make partner before intracytoplasmic sperm injection. Fertil. Steril. 72(4), 670-673 (1999).
14. Attia AM, Al-Inany HG, Farquhar C, Proctor M. Gonadotropins for idiopathic male factor subfertility. Cochrane Database Syst. Rev. 4, CD005071 (2007).
15. World Health Organization. A double blind study trail of clomiphene citrate for the treatment of idiopathic male infertility. Int. J. Androl. 15(4), 299-307 (1992).
16. Vandekerckhove P, Lilford R, Vail A, Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst. Rev. 4, CD000151 (1996).
17. Whitten SJ, Nangia AK, Kolettis PN. Select patients with hypogonadotropic hypogonadism may respond to treatment with clomiphene citrate. Fertil. Steril. 86(6), 1664-1668 (2006).
18. Kamischke A, Nieschlag E. Analysis of medical treatment of male infertility. Hum. Reprod. 14(Suppl. 1), 1-23 (1999).
19. Köhn FM, Erdmann I, Oeda T, el Mulla KF, Schiefer HG, Schill WB. Influence of urogenital infections on sperm functions. Andrologia 30(Suppl. 1), 73-80 (1998).
20. Rose BI, Scott B. Sperm motility, morphology, hyperactivation, and ionophore-induced acrosome reactions after overnight incubation with mycoplasmas. Fertil. Steril. 61(2), 341-348 (1994).
21. Diemer T, Ludwig M, Huwe P, Hales DB, Weidner W. Influence of urogenital infection on sperm function. Curr. Opin. Urol. 10(1), 39-44 (2000).
22. Diemer T, Weidner W, Michelmann HW, Schiefer HG, Rovan E, Mayer F. Influence of Escherichia coli on motility parameters of human spermatozoa in vitro. Int. J. Androl. 19(5), 271-277 (1996).
23. Núñez-Calonge R, Caballero P, Redondo C, Baquero F, Martínez-Ferrer M, Meseguer MA. Ureaplasma urealyticum reduces motility and induces membrane alterations in human spermatozoa. Hum. Reprod. 13(10), 2756-2761 (1998).
24. Kessopoulou E, Powers HJ, Sharma KK et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil. Steril. 64(4), 825-831 (1995).
25. Geva E, Bartoov B, Zabludovsky N, Lessing JB, Lerner-Geva L, Amit A. The effect of antioxidant treatment on human spermatozoa. and fertilization rate in an in vitro fertilization program. Fertil. Steril. 66(3), 430-434 (1996).
26. Greco E, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, Tesarik J. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J. Androl. 26(3), 349-353 (2005).
27. Song GJ, Norkus EP, Lewis V. Relationship between seminal ascorbic acid and sperm DNA integrity in infertile men. Int. J. Androl. 29(6), 569-575 (2006).
28. Kumar TR, Wiseman AL, Kala G, Kala SV, Matzuk MM, Lieberman MW. Reproductive defects in γ-glutamyl transpeptidase-deficient mice. Endocrinology 141(11), 4270-4277 (2000).
29. Comhaire FH, Christophe AB, Zalata AA, Dhooge WS, Mahmoud AM, Depuydt CE. The effects of combine conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot. Essent. Fatty Acids 63(3), 159-165 (2000).
30. Lenzi A, Picardo M, Gandini L, Dondero F. Lipids of sperm plasma membrane: from polyunsaturated fatty acid considered as markers of sperm function to possible scavenger therapy. Hum. Reprod. Update (2), 246-256 (1996).
31. Lenzi A, Gandini L, Lombardo F et al. Polyunsaturaied fatty-acids of germ cell membranes, glutathione and blutathione-dependent enzyme-PHGPx: from basic to clinic. Contraception (65), 301-304 (2002).
32. Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA, Steegers-Theunissen RP. Effects of folic acid and zinc sulfate on male factor subfertility: a double blind, randomized, placebo-controlled trial. Fertil. Steril. 77(3), 491-498 (2002).
33. Prasad AS. Discovery of human zinc deficiency and studies in an experimental human model. Am. J. Clin. Nutr. (53), 403-412 (1991).
34. Netter A, Hartoma R, Nahoul K. Effect of zinc administration on plasma testosterone, dihydrotestosterone, and sperm count. Arch. Andr. 7(1), 69-73 (1981).
35. Abbasi AA, Prasad AS, Rabbani P, DuMouchelle E. Experimental zinc deficiency in man. Elfect on testicular function. J. Lab. Clin. Med. (96), 544-550 (1980).
36. Lenzi A, Lombardo F, Sgrò P et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind cross over trial. Fertil. Steril. 79(2), 292-300 (2003).
37. Lenzi A, Sgrò P, Salacone P et al. A placebo-controlled double-blind randomized trial of the use of combined L-carnitine and L-acetyl-carnitine treatment in men with asthenozoospermia. Fertil. Steril. 81(6), 1578-1584 (2004).
38. Evers JL, Collins JA, Vandekerckhove P. Surgery or embolisation for varicocele in subfertile men. Cochrane Database Syst. Rev. 1, CD000479 (2001).
39. Cayan S, Erdemir F, Ozbey I, Turek PJ, Kadiolu A, Tellalolu S. Can varicocelectomy significantly change the way couples use assisted reproductive technologies? J. Urol. 167(4), 1749-1752 (2002).
40. Purohit RS, Wu DS, Shinohara K, Turek PJ. A prospective comparison of 3 diagnostic methods to evaluate ejaculatory duct obstruction. J. Urol. 171(1), 232-236 (2004).
41. Turek PJ, Magana JO, Lipshultz LI. Semen parameters before and after transurethral surgery for ejaculatory duct obstruction. J. Urol. 155(4), 1291-1293 (1996).
42. Sharlip ID. What is the best pregnancy rate that may be expected from vasectomy reversal? J. Urol. (149), 1469-1471 (1993).
43. Temple-Smith PD, Southwick GJ, Yates CA, Trounson AO, de Kretser DM. Human pregnancy by in vitro fertilization (IVF) using sperm aspirated from the epididymis. J In Vitro Fert. Embryo Transf. 2(3), 119-122 (1985).
44. Goldstein M, Tanrikut C. Microsurgical management of male infertility. Nat. Clin. Pract. Urol. 3(7), 381-391 (2006).
45. Van Peperstraten A, Proctor ML, Johnson NP, Philipson G. Techniques for surgical retrieval of sperm prior to ICSI four azoospermia. Cochrane Database Syst. Rev. 3, CD002807 (2006).
46. Donoso P, Toumaye H, Devroey P. Which is the best sperm retrieval technique for non-obstructive azoospermia? A systematic review. Hum. Reprod Update (13), 539-549 (2007).
47. Jarow JP, Sharlip ID, Belker AM et al. Male Infertiliry Best Practice Policy Committee of the American Urological Association Inc. Best practice policies for male infertility. J. Urol. 167(5), 2138-2144 (2002).
48. Schlegel PN. Is assisted reproduction the optimal treatment for varicocele-associated male infertility? A cost-effectiveness analysis. Urology 49(1), 83-90 (1997).
49. Penson D, Paltiel A, Krumholz H, Palter S. The cost-effectiveness of treatment for varicocele related infertility. J. Urol. 168(6), 2490-2494 (2002).
50. Meng M, Greene K, Turek P. Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility. J. Urol. 174(5), 1926-1931 (2005).
51. Kolettis PN, Thomas AJ Jr. Vasoepididymostomy for vasectomy reversal: a critical assessment in the era of intracytoplasmic sperm injection. J. Urol. 158(2), 467-470 (1997).
52. Pavlovich CP, Schlegel PN. Fertility options after vasectomy: a cost-effectiveness analysis. Fertil. Steril. 67(1), 133-141 (1997).
53. Heidenreich A, Altmann P, Engelmann UH. Microsurgical vasavasostomy versus microsurgical. epididymal sperm aspiration/testicular extraction of sperm combined with intracytoplasmic sperm injection. A cost benefit analysis. Eur. Urol. 37(5), 609-614 (2000).
54. Pasqualotto F, Lucon A, Sobreiro B, Pasqualotto E, Arap S. The best infertility treatment for vasectomized men, assisted reproduction or vasectomy reversal? Rev. Hosp. Clin. Fac. Med. S. Paulo 59(5), 312-315 (2004).
55. Hsieh MH, Meng MV, Turek PJ. Markov modeling of vasectomy reversal and ART for infertility: how do obstructive interval and female partner age influence cost effectiveness? Fertil. Steril. 88(4), 840-846 (2007).
56. Nieschlag E, Hertle L, Fischedick A et al. Update on treatment of varicocele: counseling as effective as occlusion of the vena spermatica. Hum. Reprod. 13, 2147-2150 (1998).
57. Madgar I, Korasik A, Weissenberg R et al. Controlled trial of high spermatic vein ligation for varicocele in infertile men. Fert. Ster. 63, 120-124 (1995).